CClinicalTrials.gg
CompletedNCT04826055Updated May 10, 2022

Biliary Limb as a Percentage From the Small Intestine Rather Than Fixed Length in Loop Bypass Surgery for Morbid Obesity

An interventional study of biliary limb as fixed length and biliary limb as a percentage from small intestine length in Obesity, Morbid, sponsored by Minia University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2022-05-10.

Sponsored by Minia University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
210
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

in all loop bypass bariatric procedure (mini gastric bypass \& single anastomosis sleeve jejunal bypass), biliary limb is fixed length. we do it as a percentage from total small intestine length rather than fixed length

Read the detailed description

in all loop bypass bariatric procedure (mini gastric bypass \& single anastomosis sleeve jejunal bypass), biliary limb is fixed length we count the length of small intestine and do it as a percentage from total small intestine length rather than fixed length

02

Conditions studied

  • Obesity, Morbid

Keywords

  • biliary limb length in bypass bariatric surgery
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

This study's enrollment of 210 is above the median of 78 across 4,878 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Minia University is the lead sponsor of 356 studies on the registry; 115 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • obese patients with BMI more than 40 or more than 35 with comorbidity
  • patients fit for laparoscopic surgery
  • give approval to share in the study

Exclusion criteria

Exclusion Criteria:

  • patients refused to share in the study
  • patients unfit for surgery
  • patients aged less than 18 and older than 50
  • patients with BMI less than 35
  • patient with previous upper abdominal surgery either for obesity or other diseases
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
210 participants (actual)

Study arms

  • Active comparator
    loop bypass with fixed biliary limb length

    in all loop bypass procedures we will don't count the total length of small intestine and make the biliary limb as a fixed from total small intestine length as mentioned in literature

    Other: biliary limb as fixed length

  • Experimental
    loop bypass with a biliary limb is a percentage of the small intestine

    in all loop bypass procedures we count the total length of small intestine and make the biliary limb as a percentage from total small intestine length rather than fixed length

    Other: biliary limb as a percentage from small intestine length

Interventions

  • Otherbiliary limb as fixed length

    n all loop bypass procedures we will don't count the total length of small intestine and make the biliary limb as a fixed from total small intestine length as mentioned in literature

  • Otherbiliary limb as a percentage from small intestine length

    in all loop bypass procedures we count the total length of small intestine and make the biliary limb as a percentage from total small intestine length rather than fixed length

06

What researchers measure

Primary outcomes

  1. effect on weight loss

    the effect on weight loss

    Time frame: one year

  2. effect on nutritional deficiency

    the effect on nutritional deficiency

    Time frame: 1 year

Secondary outcomes

  1. operative time

    operative time from skin incision to skin closure

    Time frame: 6 hours

  2. effect on obesity comorbidities

    the effect on improvement of obesity related comorbidities

    Time frame: 1 year

  3. early complications

    the operative and postoperative 30 days complications

    Time frame: 30 days

  4. late complications

    the late reported complications

    Time frame: 1 year

07

Study locations

1 site
  • Faculty of medicine
    Minya, 61511, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 10, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04826055
Lead sponsor
Minia University
Responsible party
Alaa Mstafa Hassan Sewefy (Assistant professor and consultant of general surgery, Minia University) — Principal investigator
First posted
Apr 1, 2021
Start date
Mar 25, 2021
Primary completion
Mar 25, 2022
Completion
Mar 25, 2022
Last update
May 10, 2022

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion